Cardiometabolic disease is associated with distinct proteomic signatures of acute disease activity in multiple sclerosis.

Okuda DT, Burgess KW, Wright CM, Jones-McCreary MC, Huddleston IJ, Santoyo JR, Punnen TG, Sguigna PV, Tardo LM, Lebrun-Frénay C, Stüve O, Tran DH, Moog TM

Open source

DOI
10.1016/j.neurot.2026.e01060
Published
2026 Sep
Container
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.neurot.2026.e01060,
  title = {Cardiometabolic disease is associated with distinct proteomic signatures of acute disease activity in multiple sclerosis.},
  author = {Okuda DT and Burgess KW and Wright CM and Jones-McCreary MC and Huddleston IJ and Santoyo JR and Punnen TG and Sguigna PV and Tardo LM and Lebrun-Frénay C and Stüve O and Tran DH and Moog TM},
  year = {2026},
  journal = {Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics},
  doi = {10.1016/j.neurot.2026.e01060},
  url = {https://doi.org/10.1016/j.neurot.2026.e01060}
}

RIS

TY  - JOUR
TI  - Cardiometabolic disease is associated with distinct proteomic signatures of acute disease activity in multiple sclerosis.
AU  - Okuda DT
AU  - Burgess KW
AU  - Wright CM
AU  - Jones-McCreary MC
AU  - Huddleston IJ
AU  - Santoyo JR
AU  - Punnen TG
AU  - Sguigna PV
AU  - Tardo LM
AU  - Lebrun-Frénay C
AU  - Stüve O
AU  - Tran DH
AU  - Moog TM
PY  - 2026
JO  - Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
DO  - 10.1016/j.neurot.2026.e01060
UR  - https://doi.org/10.1016/j.neurot.2026.e01060
ER  - 

APA

DT, O., KW, B., CM, W., MC, J., IJ, H., JR, S., TG, P., PV, S., LM, T., C, L., O, S., DH, T., & TM, M. (2026). Cardiometabolic disease is associated with distinct proteomic signatures of acute disease activity in multiple sclerosis.. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics. https://doi.org/10.1016/j.neurot.2026.e01060

Source records